The "Super Flu" sweeping through the US and UK is not a super strain of flu, but rather a new variant of influenza A H3N2, known as subclade K. The term "super flu" is misleading, as this particular strain has not made the virus more deadly.
The 2024-25 flu season has been deemed the most severe since 2017-18 in the US, and the UK has seen an early outbreak that began before any other country. Genetic analysis revealed that nearly 87 percent of H3N2 viruses detected in the UK since late August are subclade K.
While this strain's mutations allow it to partially evade immunity from previous infections or vaccines, the danger posed by it is no different from traditional strains of H3N2. In fact, the US influenza pandemic peaked in early February, with 87.3 percent of the country experiencing high epidemic levels for 11 consecutive weeks.
The reason for this early outbreak may be due to a decline in population immunity and physical strength after the record-breaking heatwave and countermeasures against COVID-19. Existing vaccines remain effective, with 70-75 percent of vaccinated children and 30-40 percent of adults not needing hospitalization after infection.
To combat this virus, it's essential to combine vaccination with basic prevention measures like hand washing, wearing a mask in crowds, and maintaining good ventilation. If symptoms appear, waiting for at least 12 hours before visiting a medical institution and taking anti-influenza medication within 48 hours of symptom onset can be beneficial.
The key is to respond calmly based on scientific understanding rather than fear. By combining vaccination with effective infection control, the risk of severe symptoms can be significantly reduced, protecting not only individual health but also that of society as a whole.
The 2024-25 flu season has been deemed the most severe since 2017-18 in the US, and the UK has seen an early outbreak that began before any other country. Genetic analysis revealed that nearly 87 percent of H3N2 viruses detected in the UK since late August are subclade K.
While this strain's mutations allow it to partially evade immunity from previous infections or vaccines, the danger posed by it is no different from traditional strains of H3N2. In fact, the US influenza pandemic peaked in early February, with 87.3 percent of the country experiencing high epidemic levels for 11 consecutive weeks.
The reason for this early outbreak may be due to a decline in population immunity and physical strength after the record-breaking heatwave and countermeasures against COVID-19. Existing vaccines remain effective, with 70-75 percent of vaccinated children and 30-40 percent of adults not needing hospitalization after infection.
To combat this virus, it's essential to combine vaccination with basic prevention measures like hand washing, wearing a mask in crowds, and maintaining good ventilation. If symptoms appear, waiting for at least 12 hours before visiting a medical institution and taking anti-influenza medication within 48 hours of symptom onset can be beneficial.
The key is to respond calmly based on scientific understanding rather than fear. By combining vaccination with effective infection control, the risk of severe symptoms can be significantly reduced, protecting not only individual health but also that of society as a whole.